ZDHHC4
Palmitoyltransferase ZDHHC4
Also known as: FLJ10479, ZDHC4_HUMAN, ZNF374
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPG8
- Gene
- ZDHHC4
- Ensembl
- ENSG00000136247
- Chromosome
- 7
- Canonical length
- 344 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
OverviewNCBI Gene
Enables palmitoyltransferase activity. Involved in positive regulation of innate immune response and protein localization to plasma membrane. Located in Golgi apparatus and endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
344 residues, UniProt reviewed canonical sequence.
>Q9NPG8|ZDHHC4
1 MDFLVLFLFY LASVLMGLVL ICVCSKTHSL KGLARGGAQI FSCIIPECLQ RAVHGLLHYL
61 FHTRNHTFIV LHLVLQGMVY TEYTWEVFGY CQELELSLHY LLLPYLLLGV NLFFFTLTCG
121 TNPGIITKAN ELLFLHVYEF DEVMFPKNVR CSTCDLRKPA RSKHCSVCNW CVHRFDHHCV
181 WVNNCIGAWN IRYFLIYVLT LTASAATVAI VSTTFLVHLV VMSDLYQETY IDDLGHLHVM
241 DTVFLIQYLF LTFPRIVFML GFVVVLSFLL GGYLLFVLYL AATNQTTNEW YRGDWAWCQR
301 CPLVAWPPSA EPQVHRNIHS HGLRSNLQEI FLPAFPCHER KKQELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZDHHC4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 5
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 44 nTPM
- tongue: 41 nTPM
- choroid plexus: 35 nTPM
- thyroid gland: 34 nTPM
- testis: 34 nTPM
- liver: 33 nTPM
Single-cell type
- early primary spermatocytes: 104 nCPM
- extravillous trophoblasts: 88 nCPM
- migrating cytotrophoblasts: 84 nCPM
- cytotrophoblasts: 80 nCPM
- decidual stromal cells: 78 nCPM
- epididymal principal cells: 68 nCPM
Immune cell
- plasmacytoid DC: 114 nTPM
- basophil: 56 nTPM
- eosinophil: 45 nTPM
- memory B-cell: 39 nTPM
- naive B-cell: 36 nTPM
- intermediate monocyte: 32 nTPM
Brain region
- midbrain: 23 nTPM
- choroid plexus: 22 nTPM
- hypothalamus: 22 nTPM
- pons: 21 nTPM
- medulla oblongata: 20 nTPM
- white matter: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.53
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of innate immune response
- protein localization to plasma membrane
- protein targeting to membrane
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZDHHC4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZDHHC4 as an antibody target. Whether an autoantibody or antibody against ZDHHC4 could matter depends on whether native ZDHHC4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZDHHC4 is annotated at the cell surface, where native ZDHHC4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ZDHHC4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...